EarlySense

EarlySense
TypePrivate
IndustryMedical Technology
Founded2004
FoundersDr. Danny Lange, Yossi Gross, Avner Halperin
Headquarters
Ramat Gan, Israel,
Waltham, Massachusetts
Area served
Worldwide
Key people
Matt Johnson (CEO)
Websiteearlysense.com

EarlySense was an Israeli medical device company with offices in the United States. It has sold its proprietary contact-free continuous monitoring technology to Hill-Rom, now Baxter International.

History

The company was founded in 2004 by Dr. Danny Lange, Yossi Gross, and Avner Halperin. The CEO is Matt Johnson.[1]

The product has two components: a sensor that is placed under a mattress and a software application.[2] The company sells a version of the product designed for use in hospitals that received 510K marketing clearance from the FDA in 2009, meaning that it is equivalent to devices already on the market.[3][4][2] It also received the CE mark in Europe.[3] In this system, the sensor measures changes in pressure applied to it through the mattress, and transmits the measurements to the software, which converts them to heart rate, breathing rate, and motion. The application can be used by nurses to monitor patients in their ward remotely; it can provide alerts if patients try to get out of bed, and can provide alerts that a patient needs to be turned in order to avoid the development of pressure ulcers.[2]

In September 2015 the company launched a version of the product for people to use at home to monitor their sleep; in this system the desktop application is replaced by a smartphone app.[5] EarlySense also provided OEM services to other companies that market the system under their own brands.[6]

The company also offers contact-free continuous monitoring (CFCM) sensors for use in healthcare settings. The sensors allow wireless monitoring of patients.[1]

See also

References

  1. ^ a b "EarlySense brings hospital care to the wireless era. Finally!". The Jerusalem Post. ISSN 0792-822X. Retrieved 2020-08-27.
  2. ^ a b c Helfand, M; Christensen, V; Anderson, J (2011). "Technology Assessment: Early Sense for Monitoring Vital Signs in Hospitalized Patients". Department of Veterans Affairs (US). Washington (DC). PMID 27606394.
  3. ^ a b "EarlySense patient monitor system gets FDA marketing nod". Globes (in Hebrew). 8 June 2009.
  4. ^ Ford, Omar (September 24, 2012). "EarlySense gives clinicians heads up in deteriorating vitals". Medical Device Daily.
  5. ^ Wasserman, Emily (September 2, 2015). "EarlySense moves patient monitoring tech to at-home setting". FierceBiotech.
  6. ^ Comstock, Jonah (2 September 2015). "EarlySense, Samsung unveil direct-to-consumer, contact-free sleep monitor". MobiHealthNews.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.